Benzinga | Nov 11, 2021 04:32PM EST

Eledon Pharmaceuticals Q3 EPS $(0.66) Misses $(0.65) Estimate

Eledon Pharmaceuticals (NASDAQ:ELDN) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.65) by 1.54 percent. This is a 83.08 percent increase over losses of $(3.90) per share from the same period last year.